Erlotinibhydrochloride(tradenameTarceva)isadrugusedtotreatnon-smallcelllungcancer,pancreaticcancerandseveralothertypesofcancer.Itisa&nbs
Erlotinib hydrochloride (trade name Tarceva) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. It is a reversible tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR). It is marketed in the United Statesby Genentech and OSI Pharmaceuticals and elsewhere by Roche. In lung cancer, it extends life by an average of 3.3 months
CAS NO:162515-68-6
CAS NO:142569-70-8
CAS NO:113020-21-6
CAS NO:3697-66-3
CAS NO:1750-42-1
CAS NO:168960-19-8
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View